|
시장보고서
상품코드
2035598
핵의학 시장 규모, 점유율 및 성장 분석 : 진단 영상별, 치료 용도별, 기기 및 기술별, 최종사용자별, 방사성 의약품별, 지역별 - 업계 예측(2026-2033년)Nuclear Medicine Market Size, Share, and Growth Analysis, By Diagnostic Imaging, By Therapeutic Applications, By Equipment & Technology, By End-Users, By Radiopharmaceuticals, By Region - Industry Forecast 2026-2033 |
||||||
세계의 핵의학 시장 규모는 2024년에 26억 달러로 평가되었고, 2025년 28억 달러에서 2033년까지 50억 3,000만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 7.6%를 보일 전망입니다.
세계 핵의학 시장은 암, 신경질환, 심혈관질환 등 만성질환의 유병률 증가에 따라 조기 발견 및 치료 계획 수립을 위한 고도의 진단법이 필수적으로 요구되고 있습니다. PET 및 SPECT 이미징과 같은 기술은 분자 수준의 생물학적 과정에 대한 귀중한 지식을 제공하여 이상 징후를 조기에 발견할 수 있게 해줍니다. 이러한 높은 정확도는 종양 발견 및 치료 효과 모니터링 등 효과적인 종양학 진료에 있어 매우 중요합니다. 또한, 하이브리드 시스템, 혁신적인 표적형 방사성 추적자 등 방사성의약품 및 영상진단 기술의 발전으로 진단의 정확성과 안전성이 향상되고 있습니다. 진단과 치료를 통합한 테라노스틱스의 등장은 맞춤형 의료의 성장을 더욱 촉진하고 의료 종사자들 사이에서 폭넓은 수용을 촉진하여 시장의 지속적인 발전을 견인하고 있습니다.
세계 핵의학 시장의 성장 요인
세계 핵의학 시장의 주요 시장 성장 촉진요인 중 하나는 고도의 진단 및 치료 기술을 필요로 하는 암, 심혈관 질환과 같은 만성 질환의 유병률 증가입니다. 핵의학은 영상진단과 표적치료에 방사성의약품을 활용하여 이들 질환의 조기발견과 치료에 매우 중요한 역할을 하고 있습니다. 또한, 고령화로 인해 효과적인 의료 개입에 대한 수요가 증가하고 있으며, 이는 핵의학 기술의 혁신을 더욱 촉진하고 있습니다. 또한, 의료진과 환자들 사이에서 핵의학의 장점에 대한 인식이 높아진 것도 세계 시장 확대와 임상 현장 도입 촉진에 기여하고 있습니다.
세계 핵의학 시장 성장 억제요인
세계 핵의학 시장의 큰 제약 중 하나는 방사성의약품의 제조 및 유통을 규제하는 엄격한 규제 프레임워크입니다. 엄격한 안전 기준과 라이선스 요건을 준수하는 것은 제조업체에게 큰 도전이 될 수 있으며, 시장 진입 지연과 운영 비용 증가로 이어질 수 있습니다. 또한, 방사성 물질의 안전한 취급 및 폐기에 대한 우려는 잠재적 투자자들을 멀리하고 시설 확장을 제한하는 요인이 될 수 있습니다. 환자 안전과 환경에 미치는 영향에 대한 관심이 높아지면서 상황이 더욱 복잡해지고, 혁신의 장벽이 되어 핵의학 분야의 전반적인 성장 잠재력을 떨어뜨리고 있습니다.
세계 핵의학 시장 동향
세계 핵의학 시장에서는 진단용 영상과 표적화된 방사성의약품 치료를 통합하는 '테라노스틱스(Ceranostics)'의 채택 확대에 힘입어 두드러진 추세를 보이고 있습니다. 이 혁신적인 접근법은 종양의 감지 정확도를 높이고, 치료적 개입을 동시에 시행할 수 있는 맞춤 치료 계획을 수립할 수 있게 하여 환자의 예후를 개선하는 데 기여하고 있습니다. 그 결과, 특히 종양학 분야에서 고급 방사성 추적자에 대한 수요가 증가하고 임상 적용이 확대되고 있습니다. 정밀의학으로의 전환은 핵의학의 양상을 바꾸고 시장 성장을 가속하는 한편, 치료 효과와 환자 치료를 최적화하기 위한 새로운 기술과 연구 방법의 개발을 촉진하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 핵의학 시장 규모 : 진단용 영상 검사별
세계의 핵의학 시장 규모 : 치료 용도별
세계의 핵의학 시장 규모 : 기기·기술별
세계의 핵의학 시장 규모 : 최종사용자별
세계의 핵의학 시장 규모 : 방사성 의약품별
세계의 핵의학 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSHGlobal Nuclear Medicine Market size was valued at USD 2.6 Billion in 2024 and is poised to grow from USD 2.8 Billion in 2025 to USD 5.03 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).
The global nuclear medicine market is significantly influenced by the rising incidence of chronic diseases, including cancer, neurological disorders, and cardiovascular issues, necessitating sophisticated diagnostic methods for early detection and treatment planning. Techniques like PET and SPECT imaging provide invaluable insights into biological processes at the molecular level, enabling timely identification of abnormalities. This precision is crucial for effective oncology practices, including tumor detection and monitoring treatment responses. Additionally, technological advancements in radiopharmaceuticals and imaging technologies, such as hybrid systems and innovative targeted radiotracers, enhance diagnostic accuracy and safety. The emergence of theranostics, which merges diagnostics with treatment, further drives personalized medicine's growth and facilitates broader acceptance among healthcare providers, propelling the market's continual progression.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Nuclear Medicine Market Segments Analysis
Global Nuclear Medicine Market is segmented by Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals and region. Based on Diagnostic Imaging, the market is segmented into SPECT Imaging and PET Imaging. Based on Therapeutic Applications, the market is segmented into Radiopharmaceutical Therapy and Brachytherapy. Based on Equipment & Technology, the market is segmented into Imaging Devices and Software Solutions. Based on End-Users, the market is segmented into Hospitals and Diagnostic Centers. Based on Radiopharmaceuticals, the market is segmented into Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Nuclear Medicine Market
One of the key market drivers for the global nuclear medicine market is the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, that require advanced diagnostic and therapeutic techniques. Nuclear medicine plays a crucial role in the early detection and treatment of these conditions, utilizing radiopharmaceuticals for both imaging and targeted therapy. Additionally, the growing aging population intensifies the demand for effective medical interventions, further fueling innovations in nuclear medicine technologies. The rising awareness among healthcare professionals and patients regarding the benefits of nuclear medicine also contributes to the market's expansion and adoption in clinical practices worldwide.
Restraints in the Global Nuclear Medicine Market
One significant restraint in the global nuclear medicine market is the stringent regulatory framework governing the production and distribution of radiopharmaceuticals. Compliance with rigorous safety standards and licensing requirements can pose substantial challenges for manufacturers, leading to delays in market entry and increased operational costs. Additionally, concerns regarding the safe handling and disposal of radioactive materials can deter potential investors and limit the expansion of facilities. The growing emphasis on patient safety and environmental impacts further complicates the landscape, creating barriers for innovation and reducing the overall growth potential of the nuclear medicine sector.
Market Trends of the Global Nuclear Medicine Market
The global nuclear medicine market is experiencing a notable trend driven by the rising adoption of theranostics, which integrates diagnostic imaging with targeted radiopharmaceutical therapy. This innovative approach allows for personalized treatment plans that enhance tumor detection and provide simultaneous therapeutic interventions, leading to improved patient outcomes. As a result, there is a growing demand for advanced radiotracers and an expansion of clinical applications, particularly within oncology. The shift towards precision medicine is reshaping the landscape of nuclear medicine, fostering market growth and encouraging the development of new technologies and methodologies aimed at optimizing treatment efficacy and patient care.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Nuclear Medicine Market Size by Diagnostic Imaging & CAGR (2026-2033)
- Market Overview
- SPECT Imaging
- Cardiac SPECT
- Oncology SPECT
- PET Imaging
- FDG-PET
- Oncologic PET
Global Nuclear Medicine Market Size by Therapeutic Applications & CAGR (2026-2033)
- Market Overview
- Radiopharmaceutical Therapy
- I-131 Treatment
- Radium-223 Therapy
- Brachytherapy
- Permanent Implants
- Temporary Implants
Global Nuclear Medicine Market Size by Equipment & Technology & CAGR (2026-2033)
- Market Overview
- Imaging Devices
- Gamma Cameras
- PET Scanners
- Software Solutions
- Image Analysis Software
- Workflow Management Systems
Global Nuclear Medicine Market Size by End-Users & CAGR (2026-2033)
- Market Overview
- Hospitals
- Academic Hospitals
- Community Hospitals
- Diagnostic Centers
- Outpatient Facilities
- Specialized Clinics
Global Nuclear Medicine Market Size by Radiopharmaceuticals & CAGR (2026-2033)
- Market Overview
- Diagnostic Radiopharmaceuticals
- Technetium-99m
- Iodine-123
- Therapeutic Radiopharmaceuticals
- Yttrium-90
- Samarium-153
Global Nuclear Medicine Market Size & CAGR (2026-2033)
- North America (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
- US
- Canada
- Europe (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bracco Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Navidea Biopharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Walgreens Boots Alliance
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Advanced Accelerator Applications
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lantheus Medical Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Northstar Medical Radioisotopes
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IBA RadioPharma Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M Health Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eczacibasi-Monrol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TAE Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Actinium Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
